Clinical Trial Update: Comparison of Glycemic Control Achieved With 2 Different Needles [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing glycemic control achieved with two different insulin needles; sponsored by Novo Nordisk A/S, the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED